Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Phase II trial of concomitant neoadjuvant chemotherapy with oxaliplatin and capecitabine and intensity-modulated radiotherapy (IMRT) in rectal cancer.

Gasent Blesa JM, Garde Noguera J, Laforga Canales JB, Giner Bosch V, Alberola A, Soler Tortosa M, Peris Godoy M, Sanchez JL, Provencio Pulla M, Alberola Candel V.

J Gastrointest Cancer. 2012 Dec;43(4):553-61. doi: 10.1007/s12029-012-9364-7.

PMID:
22371167
2.

Old and new insights in the treatment of thyroid carcinoma.

Gasent Blesa JM, Grande Pulido E, Provencio Pulla M, Alberola Candel V, Laforga Canales JB, Grimalt Arrom M, Martin Rico P.

J Thyroid Res. 2010 Apr 13;2010:279468. doi: 10.4061/2010/279468.

3.

Phase II trial of oxaliplatin and capecitabine after progression to first-line chemotherapy in androgen-independent prostate cancer patients.

Gasent Blesa JM, Giner Marco V, Giner-Bosch V, Cerezuela Fuentes P, Alberola Candel V.

Am J Clin Oncol. 2011 Apr;34(2):155-9. doi: 10.1097/COC.0b013e3181d6b453.

PMID:
20539209
4.

Melanoma: from darkness to promise.

Gasent Blesa JM, Grande Pulido E, Alberola Candel V, Provencio Pulla M.

Am J Clin Oncol. 2011 Apr;34(2):179-87. doi: 10.1097/COC.0b013e3181d6b427. Review.

PMID:
20498590
5.

Experience with fulvestrant acetate in castration-resistant prostate cancer patients.

Gasent Blesa JM, Alberola Candel V, Giner Marco V, Giner-Bosch V, Provencio Pulla M, Laforga Canales JB.

Ann Oncol. 2010 May;21(5):1131-2. doi: 10.1093/annonc/mdq010. Epub 2010 Feb 5. No abstract available.

PMID:
20139153
6.

Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patients.

Alberola Candel V, Carrato Mena A, Díaz-Rubio García E, Gascón Vilaplana P, González Barón M, Martín Jiménez M, Alba Conejo E, Cassinello Espinosa J, Colomer R, Cruz Hernández JJ, Barnadas i Molins A, Camps Herrero C, Casas Fernández de Tejerina AM, Carulla Torrent J, Constenla Figueiras M, Gavilá Gregori J, Isla Casado MD, Massuti Sureda B, Provencio Pulla M, Rodríguez Sánchez CA, Sanz Ortiz J; Spanish Society of Medical Oncology..

Clin Transl Oncol. 2009 Nov;11(11):727-36.

PMID:
19917536
7.

Management of platinum-resistant ovarian cancer with the combination of pemetrexed and gemcitabine.

Gasent Blesa JM, Alberola Candel V, Provencio Pulla M, Esteban González E, Martín Algarra S.

Clin Transl Oncol. 2009 Jan;11(1):35-40.

PMID:
19155202
8.
9.

Final Report of the First Refractory Germ Cell Tumor Treated with Sunitinib Malate.

Gasent Blesa JM, Grande Pulido E, Laforga Canales J, Alberola Candel V.

Case Rep Oncol. 2009 Dec 11;2(3):234-241.

10.

Young male patient with bilateral synchronous testicular germ cell tumour. Considerations for partial orchiectomy.

Gasent Blesa JM, Laforga Canales J, Romero Pérez P, Amat Cecilia M, Merenciano Cortina FJ, Rafie Macketli W, Alberola Candel V.

Clin Transl Oncol. 2008 Dec;10(12):850-2.

PMID:
19068458
11.

Langerhans cell histiocytosis.

Gasent Blesa JM, Alberola Candel V, Solano Vercet C, Laforga Canales J, Semler C, Pérez Antolí MR, Rodríguez-Galindo C.

Clin Transl Oncol. 2008 Nov;10(11):688-96. Review.

PMID:
19015065
12.

Circulating tumor cells in breast cancer: methodology and clinical repercussions.

Gasent Blesa JM, Alberola Candel V, Esteban González E, Vidal Martínez J, Gisbert Criado R, Provencio Pulla M, Laforga Canales J, Pachmann K.

Clin Transl Oncol. 2008 Jul;10(7):399-406. Review.

PMID:
18628068
13.

Screening and chemoprevention in lung cancer.

Gasent Blesa JM, Esteban González E, Alberola Candel V.

Clin Transl Oncol. 2008 May;10(5):274-80. Review.

PMID:
18490244
14.

Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer.

Pérez Carrión R, Alberola Candel V, Calabresi F, Michel RT, Santos R, Delozier T, Goss P, Mauriac L, Feuilhade F, Freue M, et al.

Ann Oncol. 1994;5 Suppl 7:S19-24.

PMID:
7873457
15.

[Thrombopenic purpura associated with human immunodeficiency virus infection. Analysis of 24 cases].

Aguilar Ligorit E, Guix García J, Benet Monforte I, Marugán de la Concha I, Escrig Orenga V, Pascual López A, Alberola Candel V, García-Conde Bru J.

Med Clin (Barc). 1989 May 6;92(17):641-5. Spanish.

PMID:
2747329
16.

p29 protein in breast cancer: relation between estrogen and progesterone receptors.

Artero Morà A, Lluch Hernandez A, Cano Sanchez A, Bueno Cañigral FJ, Martin Quetglas G, Alberola Candel V, Garcia-Conde Bru J.

Tumori. 1989 Apr 30;75(2):113-6.

PMID:
2741216
17.

[Syndrome of persistent generalized lymphadenopathies parenteral drug addicts. Clinical, immunological and histopathological study of 18 cases].

Aguilar Ligorit E, Guix García J, Sánchez Fernández de Sevilla C, Escrig Orenga V, Alberola Candel V, Llombart Bosch A, García-Conde Bru J.

Med Clin (Barc). 1988 Sep 10;91(7):256-60. Spanish. No abstract available.

PMID:
3193832
18.

Adjuvant chemotherapy with adriamycin, fluorouracil, cyclophosphamide, methotrexate, with or without tamoxifen in operable breast cancer.

Lluch-Hernandez A, Cervantes-Ruiperez A, Anton-Torres A, Aviño-Viguer J, Martinez-Agullo A, Mengual-Colomer F, Ciudad-Platero J, Alberola-Candel V, Garcia-Conde J.

Tumori. 1987 Oct 31;73(5):467-73.

PMID:
3686680
19.

[Serum immunoglobulins in parenteral drug addicts].

Aguilar Ligorit E, Guix García J, Sánchez Mañez A, Pascual López A, San Martín Echauri B, Lluch Hernández A, Alberola Candel V, García-Conde Brú J.

Med Clin (Barc). 1987 Sep 26;89(9):370-3. Spanish. No abstract available.

PMID:
3669786
20.

[Blood cell counts in parenteral drug addicts].

Aguilar Ligorit E, Guix García J, Ample Guillén I, Escrig Orenga V, Pascual López A, Alberola Candel V, García-Conde Bru J.

Sangre (Barc). 1987;32(4):409-15. Spanish. No abstract available.

PMID:
3660179

Supplemental Content

Loading ...
Support Center